Selected research
Industry Research
Adult and Pediatric Vaccines Industry Research Report 2026
Market perspective
The global Adult and Pediatric Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Adult and Pediatric Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Adult and Pediatric Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Adult and Pediatric Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Adult and Pediatric Vaccines include Sanofi, Johnson and Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Sinovac Biotech, AstraZeneca and Takeda Pharmaceutical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Adult and Pediatric Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Adult and Pediatric Vaccines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Adult and Pediatric Vaccines Market by Company
Sanofi
Johnson and Johnson
Novartis
Merck
Pfizer
GlaxoSmithKline
Sinovac Biotech
AstraZeneca
Takeda Pharmaceutical
LG Life Sciences
Bavarian Nordic
Adult and Pediatric Vaccines Segment by Type
Adult Vaccines
Pediatric Vaccines
Adult and Pediatric Vaccines Segment by Application
Hospitals
Medical Care Centers
Others
Adult and Pediatric Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult and Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult and Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult and Pediatric Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Adult and Pediatric Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Adult Vaccines
- Pediatric Vaccines
Applications
- Hospitals
- Medical Care Centers
- Others
Companies covered
- Sanofi
- Johnson and Johnson
- Novartis
- Merck
- Pfizer
- GlaxoSmithKline
- Sinovac Biotech
- AstraZeneca
- Takeda Pharmaceutical
- LG Life Sciences
- Bavarian Nordic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Adult and Pediatric Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Adult Vaccines
- 2.2.3 Pediatric Vaccines
- 2.3 Adult and Pediatric Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Medical Care Centers
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Adult and Pediatric Vaccines Breakdown Data by Type
- 3.1 Global Adult and Pediatric Vaccines Historic Market Size by Type (2021-2026)
- 3.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2027-2032)
4 Adult and Pediatric Vaccines Breakdown Data by Application
- 4.1 Global Adult and Pediatric Vaccines Historic Market Size by Application (2021-2026)
- 4.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Adult and Pediatric Vaccines Market Perspective (2021-2032)
- 5.2 Global Adult and Pediatric Vaccines Growth Trends by Region
- 5.2.1 Global Adult and Pediatric Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Adult and Pediatric Vaccines Historic Market Size by Region (2021-2026)
- 5.2.3 Adult and Pediatric Vaccines Forecasted Market Size by Region (2027-2032)
- 5.3 Adult and Pediatric Vaccines Market Dynamics
- 5.3.1 Adult and Pediatric Vaccines Industry Trends
- 5.3.2 Adult and Pediatric Vaccines Market Drivers
- 5.3.3 Adult and Pediatric Vaccines Market Challenges
- 5.3.4 Adult and Pediatric Vaccines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Adult and Pediatric Vaccines Players by Revenue
- 6.1.1 Global Top Adult and Pediatric Vaccines Players by Revenue (2021-2026)
- 6.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2021-2026)
- 6.2 Global Adult and Pediatric Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Adult and Pediatric Vaccines Head Office and Area Served
- 6.4 Global Adult and Pediatric Vaccines Players, Product Type & Application
- 6.5 Global Adult and Pediatric Vaccines Manufacturers Established Date
- 6.6 Global Adult and Pediatric Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Adult and Pediatric Vaccines Market Size (2021-2032)
- 7.2 North America Adult and Pediatric Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 7.4 North America Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Adult and Pediatric Vaccines Market Size (2021-2032)
- 8.2 Europe Adult and Pediatric Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 8.4 Europe Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Adult and Pediatric Vaccines Market Size (2021-2032)
- 9.2 Asia-Pacific Adult and Pediatric Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Adult and Pediatric Vaccines Market Size (2021-2032)
- 10.2 South America Adult and Pediatric Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 10.4 South America Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Adult and Pediatric Vaccines Market Size (2021-2032)
- 11.2 Middle East & Africa Adult and Pediatric Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sanofi
- 12.1.1 Sanofi Company Information
- 12.1.2 Sanofi Business Overview
- 12.1.3 Sanofi Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.1.4 Sanofi Adult and Pediatric Vaccines Product Portfolio
- 12.1.5 Sanofi Recent Developments
- 12.2 Johnson and Johnson
- 12.2.1 Johnson and Johnson Company Information
- 12.2.2 Johnson and Johnson Business Overview
- 12.2.3 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.2.4 Johnson and Johnson Adult and Pediatric Vaccines Product Portfolio
- 12.2.5 Johnson and Johnson Recent Developments
- 12.3 Novartis
- 12.3.1 Novartis Company Information
- 12.3.2 Novartis Business Overview
- 12.3.3 Novartis Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.3.4 Novartis Adult and Pediatric Vaccines Product Portfolio
- 12.3.5 Novartis Recent Developments
- 12.4 Merck
- 12.4.1 Merck Company Information
- 12.4.2 Merck Business Overview
- 12.4.3 Merck Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.4.4 Merck Adult and Pediatric Vaccines Product Portfolio
- 12.4.5 Merck Recent Developments
- 12.5 Pfizer
- 12.5.1 Pfizer Company Information
- 12.5.2 Pfizer Business Overview
- 12.5.3 Pfizer Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.5.4 Pfizer Adult and Pediatric Vaccines Product Portfolio
- 12.5.5 Pfizer Recent Developments
- 12.6 GlaxoSmithKline
- 12.6.1 GlaxoSmithKline Company Information
- 12.6.2 GlaxoSmithKline Business Overview
- 12.6.3 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.6.4 GlaxoSmithKline Adult and Pediatric Vaccines Product Portfolio
- 12.6.5 GlaxoSmithKline Recent Developments
- 12.7 Sinovac Biotech
- 12.7.1 Sinovac Biotech Company Information
- 12.7.2 Sinovac Biotech Business Overview
- 12.7.3 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.7.4 Sinovac Biotech Adult and Pediatric Vaccines Product Portfolio
- 12.7.5 Sinovac Biotech Recent Developments
- 12.8 AstraZeneca
- 12.8.1 AstraZeneca Company Information
- 12.8.2 AstraZeneca Business Overview
- 12.8.3 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.8.4 AstraZeneca Adult and Pediatric Vaccines Product Portfolio
- 12.8.5 AstraZeneca Recent Developments
- 12.9 Takeda Pharmaceutical
- 12.9.1 Takeda Pharmaceutical Company Information
- 12.9.2 Takeda Pharmaceutical Business Overview
- 12.9.3 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.9.4 Takeda Pharmaceutical Adult and Pediatric Vaccines Product Portfolio
- 12.9.5 Takeda Pharmaceutical Recent Developments
- 12.10 LG Life Sciences
- 12.10.1 LG Life Sciences Company Information
- 12.10.2 LG Life Sciences Business Overview
- 12.10.3 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.10.4 LG Life Sciences Adult and Pediatric Vaccines Product Portfolio
- 12.10.5 LG Life Sciences Recent Developments
- 12.11 Bavarian Nordic
- 12.11.1 Bavarian Nordic Company Information
- 12.11.2 Bavarian Nordic Business Overview
- 12.11.3 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2021-2026)
- 12.11.4 Bavarian Nordic Adult and Pediatric Vaccines Product Portfolio
- 12.11.5 Bavarian Nordic Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst